Saline breast implant research
This article was originally published in The Gray Sheet
Potential autoimmune reaction to breast implants may be linked to the implants' silicone shell and not the contents of the prostheses, Henry Claman, MD, University of Colorado Health Sciences Center, Denver, reports to FDA. Both saline- and silicone gel-filled breast implants employ a silicone shell. In Jan. 26 comments on FDA's proposed call for saline-filled breast implants, Claman says his study results found that "there was no correlation between antinuclear antibody [ANA] positivity," which indicates autoimmune response, and the type of implant. "Thus, a positive ANA might be related to the silicone shell rather than the contents." Claman's research on over 100 patients recently was submitted to the Western Journal of Medicine.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.